Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03150550
Other study ID # CHU-321
Secondary ID 2016-A00048-43
Status Recruiting
Phase N/A
First received May 4, 2017
Last updated May 10, 2017
Start date January 21, 2017
Est. completion date September 2018

Study information

Verified date May 2017
Source University Hospital, Clermont-Ferrand
Contact Patrick LACARIN
Phone 04 73 75 11 95
Email placarin@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Among behavioral cognitive psychotherapies, new "Mindfulness" interventions allow patient to identify, pay attention and accept external (sensory stimuli) and internal (cognition and emotions) phenomena. This "to do with" training has yielded promising results in stress management, prevention of depressive relapse, management of craving and an increase in self-efficacy. Few studies (none in France) have attempted to measure the efficacy of this technique on alcohol relapse, in particular by comparing it with a usual management strategy (conventional relapse prevention therapy).

The main objective of this study is to compare the efficacy on alcoholic relapse (measured in the "first glass" consumed), from a Mindfulness therapeutic program to a conventional Relapse Prevention program. Secondary objectives are to demonstrate the efficacy of this program on craving, self-efficacy, and secondary endpoints of relapse (massive alcoholism, number of alcoholisation days).


Description:

Each patient will perform 12 psychotherapeutic sessions (Mindfulness or Relapse Prevention) over a period of 6 weeks. Patients will be evaluated by a practitioner different from the practitioner who makes the psychotherapeutic management.

Patients will be assessed at inclusion (Initial visit), after the 12 sessions of management (M0), 1 month (M1), 2 month (M2), 3 month (M3), 4 month (M4), 5 month (M5), 6 month (M6), after initial visit as follows

Initial Visit

- Signature of an informed consent form.

- Demographic characteristics (gender, age, family status, professional status, level of education …)

- Clinical data (patient status, ongoing pharmacological treatment, withdrawal, previous CBT ...)

- Criteria and severity of alcohol dependence (DSM 5)

- Evaluation of depressive symptomatology and severity (HAM-D)

- Level of pre-intervention alcohol consumption (AUDIT-C)

- "Binge drinking" consumption

- Craving before alcohol withdrawal (EVA craving)

- Mindfulness Skills (KIMS)

- Self-efficacy to remain abstinent (QAE-Alcohol)

- Drinking habits (QHPBA)

After the 12 sessions (M0)

- Data on treatments in progress or change in treatment

- Depressive symptomatology and severity (HAM-D)

- Level of alcohol consumption in post-intervention (AUDIT-C)

- "Binge drinking" consumption

- Craving after alcohol withdrawal (EVA craving)

- Mindfulness Skills (KIMS)

- Self-efficacy to remain abstinent (QAE-Alcohol)

- Distribution of the 1st Daily Alcohol Logbook (TLFB)

At 1 month (M1)

- Return of the 1st Daily Alcohol Logbook (TLFB)

- Data on treatments in progress or change in treatment

- Mindfulness Skills (KIMS)

- "Binge drinking" consumption

- Self-efficacy to remain abstinent (QAE-Alcohol)

- Distribution of the 2nd Daily Alcohol Logbook (TLFB)

At 2 month (M2)

- Return of the 2nd Daily Alcohol Logbook (TLFB)

- Data on treatments in progress or change in treatment

- Mindfulness Skills (KIMS)

- "Binge drinking" consumption

- Self-efficacy to remain abstinent (QAE-Alcohol)

- Distribution of the 3th Daily Alcohol Logbook (TLFB)

At 3 month (M3)

- Return of the 3th Daily Alcohol Logbook (TLFB)

- Data on treatments in progress or change in treatment

- Mindfulness Skills (KIMS)

- "Binge drinking" consumption

- Self-efficacy to remain abstinent (QAE-Alcohol)

- Distribution of the 4th Daily Alcohol Logbook (TLFB)

At 4 month (M4)

- Return of the 4th Daily Alcohol Logbook (TLFB)

- Data on treatments in progress or change in treatment

- Mindfulness Skills (KIMS)

- "Binge drinking" consumption

- Self-efficacy to remain abstinent (QAE-Alcohol)

- Distribution of the 5th Daily Alcohol Logbook (TLFB)

At 5 month (M5)

- Return of the 5th Daily Alcohol Logbook (TLFB)

- Data on treatments in progress or change in treatment

- Mindfulness Skills (KIMS)

- "Binge drinking" consumption

- Self-efficacy to remain abstinent (QAE-Alcohol)

- Distribution of the 6th Daily Alcohol Logbook (TLFB)

At 6 month (M6)

- Return of the 6th Daily Alcohol Logbook (TLFB)

- Data on treatments in progress or change in treatment

- Mindfulness Skills (KIMS)

- "Binge drinking" consumption

- Self-efficacy to remain abstinent (QAE-Alcohol)


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date September 2018
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Male or female aged 18 to 75 (including landmarks)

- Patients in withdrawal for alcohol dependence according to DSM IV criteria (1994); hospital or outpatient withdrawal of more than 10 days and less than 10 weeks.

Exclusion Criteria:

- Psychiatric comorbidity (dipsomaniac alcoholism, anteriority of one or more hypomanic or manic episodes, psychoses, severe depression, severe suicidal risk)

- Other addiction syndrome than tobacco and alcohol

- Problems that impede participation in a group, such as severe borderline personality disorder; antisocial personality; tendency to dissociation; phobias of interceptive type (panic attacks and hypochondria ...)

- Problems preventing the completion of questionnaires, such as cognitive dysfunctions, dysfunctions of attention and concentration skills, or a language barrier

- Severe recurring pathology

- Need for individual weekly follow-up

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness practice
Mindfulness interventions are behavioral cognitive psychotherapies which allow patient to identify, pay attention and accept external (sensory stimuli) and internal (cognition and emotions) phenomena.
Relapse prevention
It's a conventional relapse prevention program which allow to measure the alcoholic relapse in the first glass consumed.

Locations

Country Name City State
France CHU Clermont-Ferrand France

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand Lundbeck SAS 37-45

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of alcoholic relapses Proportion of patients with an alcohol consumption of at least one glass of alcohol 6 month
Secondary Alcohol relapse time Measurement : Number of days elapsed between the end of treatment and the first relapse compare between the two interventions (classic or "mindfulness") 6 month
Secondary Delay in "heavy drinking" relapse Measurement : Number of days elapsed between the end of treatment and the first heavy drinking (=4 glasses of alcohol for women and =6 glasses of alcohol for men) compare between the two interventions (classic or "mindfulness") 6 month
Secondary Frequency of consumption Measurement : Number of consumption days during 6 month compare between the two interventions (classic or "mindfulness") 6 month
Secondary Daily quantities consumed Measurement : Number of standard glasses consumed per day during 6 month compare between the two interventions (classic or "mindfulness") 6 month
Secondary Degree of mindfulness skills Measurement : Score at the KIMS Scale (Kentucky Inventory of Mindfulness Skills) evaluated each month, compare before and after intervention (classic or "mindfulness") 6 month
Secondary Severity of alcohol craving Measurement: Assessed daily on a VAS craving (Visual analogue scale) in the daily observation book, compare before and after intervention (classic or "mindfulness") 6 month
Secondary Level of self-efficacy Measurement: Assessed daily on a VAS self-efficacy (Visual analogue scale) in the daily observation book, compare before and after intervention (classic or "mindfulness") 6 month
See also
  Status Clinical Trial Phase
Recruiting NCT04788004 - Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse
Recruiting NCT05684094 - Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function N/A
Completed NCT03406039 - Testing the Efficacy of an Online Integrated Treatment for Comorbid Alcohol Misuse and Emotional Problems N/A
Completed NCT03573167 - Mobile Phone-Based Motivational Interviewing in Kenya N/A
Completed NCT04817410 - ED Initiated Oral Naltrexone for AUD Phase 1
Active, not recruiting NCT04267692 - Harm Reduction Talking Circles for American Indians and Alaska Natives With Alcohol Use Disorders N/A
Completed NCT03872128 - The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders Phase 1
Completed NCT02989662 - INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers Phase 1/Phase 2
Recruiting NCT06030154 - Amplification of Positivity for Alcohol Use N/A
Active, not recruiting NCT05419128 - Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19 N/A
Completed NCT04564807 - Testing an Online Insomnia Intervention N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04203966 - Mental Health and Well-being of People Who Seek Help From Their Member of Parliament
Recruiting NCT05861843 - Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Enrolling by invitation NCT04128761 - Decreasing the Temporal Window in Individuals With Alcohol Use Disorder N/A
Not yet recruiting NCT06444243 - Psilocybin-assisted Therapy for Alcohol Use Disorder Phase 2
Not yet recruiting NCT06337721 - Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults N/A
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Enrolling by invitation NCT02544581 - Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare N/A